Skin drug boosts CollaGenex

Thu, 13 Sep 2007 00:16:51 +0000

CollaGenex Pharmaceuticals to Present at the Thomas Weisel Partners Healthcare Conference 2007 on September 6th (Business Wire via Yahoo! Finance)

Sun, 09 Sep 2007 23:16:05 +0000

NEWTOWN, Pa.----CollaGenex Pharmaceuticals, Inc. today announced that Nancy C. Broadbent, chief financial officer, will present at the Thomas Weisel Partners Healthcare Conference 2007.

CollaGenex Pharmaceuticals Announces Highly Positive Results of Phase 2 Dose-Finding Trial of Col-118 for the Treatment ... (Business Wire via Yahoo! Finance)
NEWTOWN, Pa.----CollaGenex Pharmaceuticals, Inc. today announced results of a Phase 2 dose-finding study designed to evaluate the safety and efficacy of Col-118 for the treatment of erythema....

Skin drug boosts CollaGenex

Sat, 08 Sep 2007 23:16:31 +0000

Bucks County Courier Times - The company recorded $13.1 million in sales for Oracea. The oral drug used to treat the skin disease rosacea, launched in July 2006. The drug was “the key driver of the significant sales growth achieved this quarter. Oracea is now the No. 1 oral ...

Decision About European Marketing Authorization for Oracea Postponed ...
Phramalive.com - * Committee of the decentralised approval procedure (CMD) refers decision to a central body of the European regulatory authorities (CHMP) * No impact on the overall result for 2007 expected MARTINSRIED/MUNICH, Germany - July 30, 2007. MediGene AG ... ...

CollaGenex Pharmaceuticals Announces Highly Positive Results of Phase 2 Dose-Finding Trial of Col-118 for the Treatment ... (Business Wire via Yahoo! Finance)

Tue, 28 Aug 2007 23:16:04 +0000

NEWTOWN, Pa.----CollaGenex Pharmaceuticals, Inc. today announced results of a Phase 2 dose-finding study designed to evaluate the safety and efficacy of Col-118 for the treatment of erythema.

CollaGenex Pharmaceuticals Reports Financial Results for the Second Quarter and First Half of 2007 (Business Wire via Yahoo! Finance)
NEWTOWN, Pa.----CollaGenex Pharmaceuticals, Inc. today reported financial results for the second quarter and six months ended June 30, 2007.

Ad hoc: MediGene AG: Decision About European Marketing Authorization for Oracea® Postponedto 2008 Börsennachrichten - ... (Stock World)
Martinsried/Munich - July 30, 2007. MediGene AG (Frankfurt, Prime Standard: MDG) has been informed by CollaGenex Pharmaceuticals Inc., that the decision about the European marketing authorization for the drug Oracea® for the treatment of the skin disease rosacea has been postponed.

German Stocks Climb; MAN, DaimlerChrysler, BMW Pace the Advance (Bloomberg.com)
July 31 (Bloomberg) -- Germany's benchmark DAX Index posted the biggest one-day gain in more than two weeks. MAN AG paced the advance after Europe's third-largest truckmaker reported its 16th consecutive profit increase.

Deutsche Boerse, Deutz, Infineon, MAN: German Equity Preview (Bloomberg.com)
July 31 (Bloomberg) -- The following stocks may rise or fall in German markets. Germany's X-DAX Index climbed 0.9 percent to 7529.98. The index provides an estimate of the DAX Index, based on trading in DAX futures after the Xetra electronic market closes....

Oracea

Mon, 27 Aug 2007 00:15:43 +0000

Oracea® treats the bumps or pimple-like blemishes of ... what makes Oracea unique ... The dosage of Oracea differs from that of doxycycline used to ...

Oracea
Oracea is the first and only oral therapy approved for rosacea patients. Oracea® has been approved by the Food and Drug Administration (FDA) to treat ...

Oracea Information from Drugs.com
Oracea information from Drugs.com, includes Oracea side effects interactions, indications ... Oracea can make birth control pills less effective. ...

Oracea, Doxycycline, side effects, interactions, overdose, dosage
Oracea is a prescription medicine to treat only the pimples or bumps on the face caused by a condition called rosacea. ... Take Oracea with a full glass of ...

Rosacea.org: A site about Rosacea
Home of the National Rosacea Society. A website about the medical condition Rosacea. ... Oracea (Or-RAY-sha) is the first orally administered, systemically delivered ......

CollaGenex Pharmaceuticals (CGPI) Tops Q2 EPS by 2c, Revises ... - StreetInsider.com (subscription)

Sun, 26 Aug 2007 00:18:33 +0000

CollaGenex Pharmaceuticals (CGPI) Tops Q2 EPS by 2c, Revises ...
StreetInsider.com (subscription), MI -Aug 7, 2007
Total revenues: Revenues from Oracea, PeriostatÂ®, Pandel, the Atrix products, contract revenues from the Primus products and grant revenue from the ...

German Stocks Climb; MAN, DaimlerChrysler, BMW Pace the Advance - Bloomberg

German Stocks Climb; MAN, DaimlerChrysler, BMW Pace the Advance
Bloomberg -Jul 31, 2007
... the biotechnology company said the European Union postponed its decision on marketing authorization for the company's Oracea skin treatment until 2008. ...

Deutsche Boerse, Deutz, Infineon, MAN: German Equity Preview - Bloomberg

Deutsche Boerse, Deutz, Infineon, MAN: German Equity Prev...

CollaGenex Pharmaceuticals Provides Update on Oracea Patent - Health - RedOrbit

Sat, 25 Aug 2007 00:16:15 +0000

... on its Website a nonfinal rejection of CGPI's patent application for Oracea. ... for the treatment of acne and acne rosacea, including Oracea(TM) and incyclinide. ...

News: CollaGenex Pharmaceuticals Provides Update on Oracea Patent. Genetic Engineering News - Biotechnology from ...
CollaGenex Pharmaceuticals Provides Update on Oracea Patent. Genetic Engineering News - Biotechnology from Bench to Business. The Leading Publication in ...

FDA OKs New Drug for Rosacea - Skin diseases, conditions and procedures on MedicineNet.com
Information relating to the skin includes skin diseases and conditions, ... 31, 2006 -- The FDA has approved the drug Oracea to help treat rosacea in adults. ...

News: CollaGenex Pharmaceuticals Announces USPTO Schedules Date for Issuance of Oracea Patent. Genetic Engineering ...
... Pharmaceuticals Announces USPTO Schedules Date for Issuance of Oracea Patent. ... In July 2006, CollaGenex launched Oracea, the first FDA-approved systemic ...

CollaGenex Pharmaceuticals Submits Response to USPTO Regarding Patent Application Covering Oracea - Health - ...
CollaGenex Pharmaceuticals, Inc. (NASDAQ: CGPI) today announced that it has submitted its response to the U.S. Patent ... rosacea, including Oracea(TM) and ......

CollaGenex Pharmaceuticals Provides Update on Oracea Patent - Health - RedOrbit

Wed, 22 Aug 2007 00:19:18 +0000

... on its Website a nonfinal rejection of CGPI's patent application for Oracea. ... for the treatment of acne and acne rosacea, including Oracea(TM) and incyclinide. ...

Oracea - Acne.org Message Boards
So now, my doctor prescribed for me Oracea. ... I have been on the website www..com and like what I read, so we shall see. ...

News: CollaGenex Pharmaceuticals Provides Update on Oracea Patent. Genetic Engineering News - Biotechnology from ...
CollaGenex Pharmaceuticals Provides Update on Oracea Patent. Genetic Engineering News - Biotechnology from Bench to Business. The Leading Publication in ...

FDA OKs New Drug for Rosacea - Skin diseases, conditions and procedures on MedicineNet.com
Information relating to the skin includes skin diseases and conditions, ... 31, 2006 -- The FDA has approved the drug Oracea to help treat rosacea in adults. ...

News: CollaGenex Pharmaceuticals Announces USPTO Schedules Date for Issuance of Oracea Patent. Genetic Engineering ...
... Pharmaceuticals Announces USPTO Schedules Date for Issuance of Oracea Patent. ... In July 2006, CollaGenex launched Oracea, the first FDA-approved systemic ......

Oracea

Tue, 21 Aug 2007 23:24:28 +0000

Oracea® treats the bumps or pimple-like blemishes of ... what makes Oracea unique ... The dosage of Oracea differs from that of doxycycline used to ...

Oracea New Drug Application
Oracea information from Drugs.com, includes Oracea side effects, interactions, indications ... New Drug Application for Oracea Accepted for Review by FDA; ...

Oracea
Oracea fights the inflammation of rosacea ... Oracea is the only oral prescription therapy approved specifically to treat the ...

Oracea Information from Drugs.com
Oracea information from Drugs.com, includes Oracea side effects interactions, indications ... Oracea can make birth control pills less effective. ...

Rosacea.org: A site about Rosacea
Home of the National Rosacea Society. A website about the medical condition Rosacea. ... Oracea (Or-RAY-sha) is the first orally administered, systemically delivered ......

CollaGenex Pharmaceuticals to Host Second Quarter and First Half ... - Business Wire (press release)

Tue, 21 Aug 2007 13:03:13 +0000

CollaGenex Pharmaceuticals to Host Second Quarter and First Half ...
Business Wire (press release), CA -Jul 26, 2007
In July 2006, CollaGenex launched Oracea(R), the first FDA-approved systemic product for the treatment of rosacea. CollaGenex's professional dermatology ...

German Stocks Climb; MAN, DaimlerChrysler, BMW Pace the Advance - Bloomberg

Deutsche Boerse, Deutz, Infineon, MAN: German Equity Preview - Bloomberg

Deutsche Boerse, Deutz, Infineon, MAN: German Equity Preview
<...

MediGene says EU postpones approval of skin disease treatment Oracea - Forbes

Tue, 21 Aug 2007 00:15:51 +0000

MediGene says EU postpones approval of skin disease treatment Oracea
Forbes, NY -Jul 30, 2007
In the US, Oracea is already approved and has been successful on the market since 2006, MediGene said. Oracea, developed by US-based CollaGenex, ...

Decision About European Marketing Authorization for Oracea ... - PharmaLive.com (press release)

Decision About European Marketing Authorization for Oracea...
PharmaLive.com (press release), PA -Jul 30, 2007
The annual peak sales potential for Oracea® in Europe is expected to be about 20 million Euro. Dr. Peter Heinrich, Chief Executive Officer of MediGene AG, ...

CollaGenex Pharmaceuticals Reports Financial Results for the ... - Business Wire (press release)

CollaGenex Pharmaceuticals Reports Financial Results for...

Decision About European Marketing Authorization for Oracea...

Tue, 14 Aug 2007 23:16:07 +0000

MediGene AG has been informed by CollaGenex Pharmaceuticals Inc., that the decision about the European marketing authorization for the drug Oracea has been postponed. The committee of the nine countries involved in the decentralised ...

Decision About European Marketing Authorization For Oracea ...
Asia Corporate News Network (press release) - Sydney,NSW,Australia About Oracea(r): Oracea(r) is the first drug for systemic short-term as well as long-term treatment of rosacea with inflammatory lesions. ...

Decision About European Marketing Authorization for Oracea...
* Committee of the decentralised approval procedure (CMD) refers decision to a central body of the European regulatory authorities (CHMP) * No impact on the overall result for.. - Read more.

Clinical and Hydrocortisone programs relating to Oracea.
Little Known Ways to Fake Luxury Watches. As the Nationals outslugged the Cincinnati Reds. CollaGenex plans to leverage these platforms to develop a. Cause the actual events or results to differ materially. ...

plus metrogel, better than 100mg doxycycline plus metrogel '
Official Title: A Clinical Trial to Determine the Effects of COL-101 Administered Once Daily With Metronidazole Topical Gel, 1% Versus Doxycycline Hyclate 100 mg Administered Once Daily Wit......

CollaGenex Pharmaceuticals to Host Second Quarter and First Half ... - Business Wire (press release)

Fri, 10 Aug 2007 23:15:38 +0000

German Stocks Climb; MAN, DaimlerChrysler, BMW Pace the Advance - Bloomberg

...

Ad hoc: MediGene AG: Decision About European Marketin. (Stock World)

Mon, 06 Aug 2007 00:15:42 +0000

Martinsried/Munich - July 30, 2007. MediGene AG (Frankfurt, Prime Standard: MDG) has been informed by CollaGenex Pharmaceuticals Inc., that the decision about the European marketing authorization for the drug Oracea® for the treatment of the skin disease rosacea has been postponed.

German Stocks Climb; MAN, DaimlerChrysler, BMW Pace the Advance (Bloomberg.com)
July 31 (Bloomberg) -- Germany's benchmark DAX Index posted the biggest one-day gain in more than two weeks. MAN AG paced the advance after Europe's third-largest truckmaker reported its 16th consecutive profit increase.

German Stocks Climb; MAN, DaimlerChrysler, BMW Pace the Advance (Bloomberg.com)
July 31 (Bloomberg) -- Germany's benchmark DAX Index rose, heading for the biggest one-day gain in more than two weeks. MAN AG shares paced the advance after Europe's third-largest truckmaker reported its 16th consecutive profit increase.

Deutsche Boerse, Deutz, Infineon, MAN: German Equity Preview (Bloomberg.com)
July 31 (Bloomberg) -- The following stocks may rise or fall in German markets. Stock symbols are in parentheses after the company names and prices are from the Xetra close unless otherwise stated.

Deutsche Boerse, Deutz, Infineon, MAN: German Equity Preview (Bloomberg.com)
July 31 (Bloomberg) -- The following stocks may rise or fall in German markets. Germany's X-DAX Index climbed 0.9 percent to 7529.98. The index provides an estimate of the DAX Index, based on trading in DAX futures after the Xetra electronic market closes....

MediGene says EU postpones approval of skin disease treatment Oracea

Sat, 04 Aug 2007 00:15:56 +0000

MARTINSRIED, Germany - MediGene AG said an EU committee postponed a decision on whether to grant European marketing authorization for skin disease treatment Oracea, for which the company acquired pan-European marketing rights from ...

Decision About European Marketing Authorization for Oracea...
* Committee of the decentralised approval procedure (CMD) refers decision to a central body of the European regulatory authorities (CHMP) * No impact on the overall result for.. - Read more.

oracea plus metrogel, better than 100mg doxycycline plus metrogel '
Combining a systemic antibiotic with metronidazole has been the mainstay of rosacea treatment for several years. What we are seeing here is updates to studies since the introduction of oracea and metrogel 1%.

Clinical and Hydrocortisone programs relating to Oracea.
Little Known Ways to Fake Luxury Watches. As the Nationals outslugged the Cincinnati Reds. CollaGenex plans to leverage these platforms to develop a. Cause the actual events or results to differ materially. ...

CollaGenex Pharmaceuticals Announces USPTO Schedules Date for ...
CollaGenex Pharmaceuticals, Inc. today announced that the US Patent and Trademark Office has informed the Company that its patent application No. 11/061866, covering Oracea®, will issue on June 19, 2007 as Patent No. 7232572 . ......

Oracea

Fri, 03 Aug 2007 00:15:48 +0000

Oracea® treats the bumps or pimple-like blemishes of ... what makes Oracea unique ... The dosage of Oracea differs from that of doxycycline used to ...

Oracea
Oracea fights the inflammation of rosacea ... Oracea is the only oral prescription therapy approved specifically to treat the ...

Oracea Information from Drugs.com
Oracea information from Drugs.com, includes Oracea side effects interactions, indications ... Oracea can make birth control pills less effective. ...

Oracea (Doxycycline) patient information - prescription drugs and medications at RxList
... the patient information for the drug Oracea (Doxycycline) and other prescription drugs and ... that comes with ORACEA before you start taking ...

Rosacea.org: A site about Rosacea
Home of the National Rosacea Society. A website about the medical condition Rosacea. ... Oracea (Or-RAY-sha) is the first orally administered, systemically delivered ......

CollaGenex Pharmaceuticals to Host Second Quarter and First Half ... - Business Wire (press release)

Sun, 29 Jul 2007 23:15:47 +0000

...

CollaGenex Pharmaceuticals to Host Second Quarter and First Half ... - Business Wire (press release)

Sun, 29 Jul 2007 00:17:05 +0000

...

CollaGenex Pharmaceuticals to Host Second Quarter and First Half ... - Business Wire (press release)

Sat, 28 Jul 2007 16:50:59 +0000

...